Published in Dermatology on June 29, 2013
Linear IgA bullous dermatosis: comparison between the drug-induced and spontaneous forms. Br J Dermatol (2013) 2.38
Comparison of two basophil activation markers CD63 and CD203c in the diagnosis of amoxicillin allergy. Clin Exp Allergy (2008) 2.15
Comparative analysis of adverse drug reactions to tetracyclines: results of a French national survey and review of the literature. Br J Dermatol (2012) 1.99
Characteristics of toxic epidermal necrolysis in patients undergoing long-term glucocorticoid therapy. Arch Dermatol (1995) 1.98
Laptop computer as a modern cause of erythema ab igne. J Eur Acad Dermatol Venereol (2009) 1.81
Risk factors for erysipelas of the leg (cellulitis): case-control study. BMJ (1999) 1.79
Poly(ADP-ribose) polymerase alleles in French Caucasians are associated neither with lupus nor with primary antiphospholipid syndrome. GRAID Research Group. Group for Research on Auto-Immune Disorders. Arthritis Rheum (1999) 1.67
Drug-specific risk of non-tuberculosis opportunistic infections in patients receiving anti-TNF therapy reported to the 3-year prospective French RATIO registry. Ann Rheum Dis (2010) 1.59
Neutrophilic dermatoses during granulocytopenia. Arch Dermatol (1995) 1.56
A multicentre study to determine the value and safety of drug patch tests for the three main classes of severe cutaneous adverse drug reactions. Br J Dermatol (2013) 1.50
Specific mucosal erosions in hypereosinophilic syndrome. Evidence for eosinophil protein deposition. Arch Dermatol (1996) 1.48
Toxic epidermal necrolysis (Lyell syndrome). J Am Acad Dermatol (1990) 1.47
Ginseng as a cause for Stevens-Johnson syndrome? Lancet (1996) 1.46
[Scabies finally getting the attention it merits!]. Ann Dermatol Venereol (2012) 1.43
Extrahepatic disease does not contraindicate hepatectomy for colorectal liver metastases. Br J Surg (2003) 1.42
Hypochromic vitiligo: delineation of a new entity. Br J Dermatol (2014) 1.42
Increased serum and blister fluid levels of creatine kinase in patients with toxic epidermal necrolysis. Br J Dermatol (1994) 1.42
Type I and type IV allergy to the insulin analogue detemir. Lancet (2007) 1.41
[Mortality following cardiac surgery in the National Health Service Hospitals of the Community of Valencia in 2007: a descriptive analysis]. Rev Esp Anestesiol Reanim (2010) 1.40
[Acne scars: epidemiology, physiopathology, clinical features and treatment]. Ann Dermatol Venereol (2006) 1.40
Cutaneous reactions after treatment with 2-chlorodeoxyadenosine. Acta Derm Venereol (1996) 1.40
Hypothermia related to air-fluidized bed. Intensive Care Med (1991) 1.39
[Etiology of ecthyma gangrenosum: four cases]. Ann Dermatol Venereol (2010) 1.39
[Treatment of seborrheic dermatitis]. Ann Dermatol Venereol (2004) 1.39
[Dermatology day-care: between official rules and reality]. Ann Dermatol Venereol (2012) 1.38
[Nephrogenic systemic fibrosis]. Ann Dermatol Venereol (2009) 1.37
Patch testing in severe cutaneous adverse drug reactions, including Stevens-Johnson syndrome and toxic epidermal necrolysis. Contact Dermatitis (1996) 1.34
Cutaneous graft-versus-host disease. Arch Dermatol (1998) 1.33
Treatment of lichen planus. An evidence-based medicine analysis of efficacy. Arch Dermatol (1998) 1.33
Involvement of cyclic AMP and nitric oxide in immunoglobulin E-dependent activation of Fc epsilon RII/CD23+ normal human keratinocytes. J Clin Invest (1994) 1.29
Drug-induced pseudolymphoma and hypersensitivity syndrome. Two different clinical entities. Arch Dermatol (1996) 1.28
Famciclovir as a possible alternative treatment in some cases of allergy to acyclovir. Contact Dermatitis (2000) 1.25
MR imaging in acute infectious cellulitis. Radiology (1994) 1.23
Evaluation of cardiac abnormalities by Doppler echocardiography in a large nationwide multicentric cohort of patients with systemic sclerosis. Ann Rheum Dis (2007) 1.21
Systemic involvement of acute generalized exanthematous pustulosis: a retrospective study on 58 patients. Br J Dermatol (2013) 1.18
Acquired hemophilia due to factor VIII inhibitors in 34 patients. Am J Med (1998) 1.17
[Management of drug reaction with eosinophilia and systemic symptoms (DRESS)]. Ann Dermatol Venereol (2010) 1.16
Herpes zoster: Burden of disease in France. Vaccine (2010) 1.15
Insecticide resistance in head lice: clinical, parasitological and genetic aspects. Clin Microbiol Infect (2012) 1.11
Clinicopathologic correlation in erythema multiforme and Stevens-Johnson syndrome. Arch Dermatol (1995) 1.09
[Dermatologic manifestations of the antiphospholipid syndrome]. Rev Med Interne (2011) 1.08
Intravenous immunoglobulin in adult Still's disease refractory to non-steroidal anti-inflammatory drugs. Clin Exp Rheumatol (1998) 1.07
[Neglected skin tumors. Three cases]. Ann Dermatol Venereol (2012) 1.07
Prognosis of generalized bullous fixed drug eruption: comparison with Stevens-Johnson syndrome and toxic epidermal necrolysis. Br J Dermatol (2013) 1.06
Sensitivity and specificity of clinical, histologic, and immunologic features in the diagnosis of paraneoplastic pemphigus. J Am Acad Dermatol (2000) 1.06
Acute swelling of the limbs: magnetic resonance pictorial review of fascial and muscle signal changes. Eur J Radiol (1999) 1.05
Cryofibrinogenaemia: a study of 49 patients. Clin Exp Immunol (2000) 1.05
Severe perturbations of the blood T cell repertoire in polymyositis, but not dermatomyositis patients. J Immunol (2001) 1.03
Sirolimus conversion for patients with posttransplant Kaposi's sarcoma. Am J Transplant (2006) 1.03
Systemic mastocytosis and bone involvement in a cohort of 75 patients. Ann Rheum Dis (2010) 1.02
Scabies and pediculosis: neglected diseases to highlight. Clin Microbiol Infect (2012) 1.01
Essential mixed cryoglobulinemia. A comparative study of dermatologic manifestations in patients infected or noninfected with hepatitis C virus. Arch Dermatol (1995) 1.01
[Herpes zoster: incidence study among "sentinel" general practitioners]. Ann Dermatol Venereol (2001) 1.00
Familial lupus erythematosus. Clinical and immunologic features of 125 multiplex families. Medicine (Baltimore) (2001) 0.99
Recurrent erysipelas: 47 cases. Dermatology (2007) 0.96
Effect of itraconazole on the pharmacokinetics of prednisolone and methylprednisolone and cortisol secretion in healthy subjects. Br J Clin Pharmacol (2001) 0.96
European guideline for the management of pediculosis pubis, 2010. Int J STD AIDS (2011) 0.95
Efficacy and safety of retapamulin ointment as treatment of impetigo: randomized double-blind multicentre placebo-controlled trial. Br J Dermatol (2008) 0.95
Clinical criteria for the diagnosis of bullous pemphigoid: a reevaluation according to immunoblot analysis of patient sera. Dermatology (2004) 0.95
Anaphylactic reaction to ranitidine and dexchlorpheniramine. Eur J Dermatol (2007) 0.94
Lymphoedema-area-restricted Sweet syndrome during G-CSF treatment. Lancet (1996) 0.92
Drug-induced toxic epidermal necrolysis (Lyell syndrome) in patients infected with the human immunodeficiency virus. J Am Acad Dermatol (1992) 0.92
Efficacy of anakinra, an IL1 receptor antagonist, in refractory Sweet syndrome. Ann Rheum Dis (2008) 0.92
Challenges for synthesising data in a network of registries for systemic psoriasis therapies. Dermatology (2012) 0.91
Validation of a flow cytometric assay detecting in vitro basophil activation for the diagnosis of muscle relaxant allergy. J Allergy Clin Immunol (1999) 0.91
Primary cutaneous posttransplant lymphoproliferative disorders in solid organ transplant recipients: a multicenter European case series. Am J Transplant (2013) 0.91
Induction of IL-10 synthesis by human keratinocytes through CD23 ligation: a cyclic adenosine 3',5'-monophosphate-dependent mechanism. J Immunol (1997) 0.91
Flow cytometric monitoring of allergen induced basophil activation. Cytometry (1995) 0.91
Evolving pattern of drug-induced toxic epidermal necrolysis. Dermatology (1993) 0.91
Bullous pemphigoid and amyotrophic lateral sclerosis: a new clue for understanding the bullous disease? Arch Dermatol (2000) 0.89
Flow cytometric evaluation of human basophils. Cytometry (1993) 0.89
Long-term outcome of medullary thyroid carcinoma in patients with normal postoperative medical imaging. Br J Cancer (2003) 0.89
Further observations on the therapy of anovulatory infertility with synthetic luteinizing hormone-releasing hormone. Fertil Steril (1974) 0.89
Annular atrophic lichen planus and Sneddon's syndrome. Dermatology (1997) 0.89
IgA antineutrophil cytoplasmic antibodies in cutaneous vasculitis. Br J Dermatol (2000) 0.88
Non-heart-beating donors: an excellent choice to increase the donor pool. Transplant Proc (2005) 0.88
Intravenous immunoglobulins-induced eczematous eruption: a long-term follow-up study. Eur J Intern Med (2008) 0.88
[Cutaneous infections in bullous pemphigoid patients treated with topical corticosteroids]. Ann Dermatol Venereol (2010) 0.88
[Cutaneous manifestation of hypersensibility to azathioprine in a Crohn's disease patient]. Gastroenterol Clin Biol (2008) 0.86
Phototoxicity and photocarcinogenesis associated with voriconazole. Med Mal Infect (2011) 0.86
Value of fine-needle aspiration in infectious cellulitis. Arch Dermatol (1996) 0.85
The antiphospholipid antibody syndrome: diagnosis, skin manifestations and current therapy. Clin Exp Rheumatol (2006) 0.85
Allergy to latex. Allergy (1992) 0.85
Mechanism of anti-inflammatory action of retinoids on keratinocytes. Lancet (1994) 0.85
[Frequency of plantar dermatophytosis. A retrospective study 2002-2003]. Ann Dermatol Venereol (2007) 0.84
Cutaneous disorders associated with hepatitis C virus infection. Ann Med Interne (Paris) (2000) 0.84
[Methotrexate in dermatology: pharmacology, indications, applications and prudent use]. Rev Med Interne (1999) 0.84
Severe reaction following sugammadex injection: hypersensitivity? J Investig Allergol Clin Immunol (2012) 0.84
Comparison of CD63 Upregulation Induced by NSAIDs on Basophils and Monocytes in Patients with NSAID Hypersensitivity. J Allergy (Cairo) (2011) 0.84
Prospective evaluation of detoxification pathways as markers of cutaneous adverse reactions to sulphonamides in AIDS. Pharmacogenetics (2000) 0.84